Home›People›Christopher Teas
CT

Christopher Teas

Chief Executive Officer, CAD Therapeutics at CAD Therapeutics.

Executive
Updated Nov 9, 2026·Latest SEC filing Oct 2, 2026·Suggest an edit

About Christopher Teas

Christopher Teas is a chief executive officer, CAD therapeutics at CAD Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Christopher Teas in the role, so the role may have started earlier or lasted longer.

CAD Therapeutics, Inc.
Chief Executive Officer, CAD Therapeutics
2026 · New York, NY
Develops an investigational treatment for people with post-traumatic stress disorder.

Key Colleagues at Startups

The people Christopher Teas works with at each company, as listed on that company's latest Form D.

CAD Therapeutics, Inc. · Form D, Oct 2, 2026
SB
Sorina Buri
Director

Sources

  1. SECCAD Therapeutics, Inc. Form D, filed Oct 2, 2026